Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

BACKGROUND AND OBJECTIVE: Pulmonary tuberculosis (TB) is a risk factor for chronic obstructive pulmonary disease (COPD); however, few clinical studies have investigated treatment effectiveness in COPD patients with destroyed lung by TB. The Indacaterol effectiveness in COPD patients with Tuberculosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Cheong-Ju, Yoon, Hyoung-Kyu, Park, Myung-Jae, Yoo, Kwang-Ha, Jung, Ki-Suck, Park, Jeong-Woong, Lim, Seong Yong, Shim, Jae Jeong, Lee, Yong Chul, Kim, Young-Sam, Oh, Yeon-Mok, Kim, Song, Yoo, Chul-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459963/
https://www.ncbi.nlm.nih.gov/pubmed/28615931
http://dx.doi.org/10.2147/COPD.S128750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459963/
https://www.ncbi.nlm.nih.gov/pubmed/28615931
http://dx.doi.org/10.2147/COPD.S128750

Ejemplares similares